Ángel
Carracedo Álvarez
Universidad de Valladolid
Valladolid, EspañaPublicacións en colaboración con investigadores/as de Universidad de Valladolid (13)
2024
2022
-
A genome-wide association study of survival in patients with sepsis
Critical Care, Vol. 26, Núm. 1
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2015
-
Predicting proliferative vitreoretinopathy: Temporal and external validation of models based on genetic and clinical variables
British Journal of Ophthalmology, Vol. 99, Núm. 1, pp. 41-48
2013
-
A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy
Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 3, pp. 1665-1678
2010
-
A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: The Retina 4 Project
Ophthalmology, Vol. 117, Núm. 12
-
Erratum: Prevalence of CYP2C9 polymorphisms in the south of Europe (Pharmacogenomics Journal (2009) DOI: 10.1038/tpj.2009.16))
Pharmacogenomics Journal
2009
-
Prevalence of CYP2C9 polymorphisms in the south of Europe
Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 306-310
2006
-
Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer
Clinical Chemistry, Vol. 52, Núm. 8, pp. 1480-1485
2004
-
The variant E233G of the rad51d gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations
International Journal of Cancer, Vol. 110, Núm. 6, pp. 845-849
2003
-
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects
Human Mutation, Vol. 22, Núm. 4, pp. 301-312
-
Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations
European Journal of Human Genetics